ANURAS logo

Anupam Rasayan India Limited

ANURAS·NSE·
₹1,152.40▼ -8.60 (-0.74%)
Market Cap13326.12 Cr
PE Ratio76.37
Volume2,46,544
Day High - Low1160.80 - 1135.40
52W High-Low1415.00 - 1047.90

Anupam Rasayan India Limited (ANURAS): company summary

The company's business has grown significantly, with annual revenue rising 64.6% and net profit increasing 38.8% year-over-year.

Anupam Rasayan India Limited (ANURAS) is a small-cap Chemicals company valued at ₹13,326 crore operating in Specialty Chemicals on the NSE and BSE.

Recent price move
Anupam Rasayan India Limited last traded at ₹1,152.4, modestly down 0.74% on the day.
Recent developments
On 2026-07-15, Anupam Rasayan signed a $300 mn LOI with Spain's BasqueVolt for battery chemical supply, though the agreement is preliminary and depends on product development and a definitive contract.
Financial performance
The company's business has grown significantly, with annual revenue rising 64.6% and net profit increasing 38.8% year-over-year. However, the net profit margin narrowed by 1.7 percentage points to 9.4%, while return on equity and return on capital employed remain low at 5.5% and 7.0%, respectively.
Valuation multiples
The stock trades at 76.4 times earnings, 4.25 times book value. It yields 0.1%.
Things to watch
The stock is 13.8% below its 52-week high, and the net profit margin has declined, which could pressure profitability. Promoter shares pledged account for 36.49% of their holding, indicating potential liquidity concerns.
Where it stands
Anupam Rasayan India Ltd has seen strong revenue growth, but profit growth has slowed, with margins narrowing. The company's recent LOI with BasqueVolt highlights potential expansion, but the stock remains below its recent high. The most significant figure is the 13.8% drop from the 52-week high.

Summarised by DocStoX's model on 2026-09-12 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

DocStoX Score
4.4/10
Weak
Fair Value
Sign in to see
ROE
5.10%
Weak
P/E
76.37x
Expensive
Debt / Equity
0.56
Moderate
Industry
Chemicals
Specialty Chemicals
Overall View
Mixed

Price performance

NIFTY 500NIFTY SMALLCAP 250
Day₹1135
₹1161
52W₹1048
₹1415
DocStoX take

Supported by growth (9.6) and risk (6.3), but held back by valuation (0.0). Growth looks strong at 9.6, but that is offset by valuation at 0.0 and momentum at 1.9. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
4.4
/10
Weak
Quality
Modest
ROE 5.1%
Valuation
Expensive
P/E 76.4×
Growth
Strong
Revenue +23.9% 5Y CAGR
Risk
Moderate
D/E 0.56
Momentum
Weak
28% of 52-week range

At a glance

Market Cap
₹13,326 Cr
52W High / Low
₹1415 / ₹1048
Dividend Yield
0.12%
Promoter Holding
59.07%
EPS (TTM)
₹15.09
Book Value
₹292.82

Key highlights

  • Profitable in all of the last 5 years
  • Profit compounding 26% a year
  • Revenue compounding 24% a year
  • 22% of promoter holding is pledged
  • Valuation is weak (0.0/10)
3 Positives4 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Chemicals stocks · Specialty Chemicals

Anupam Rasayan India Limited peers in Chemicals

Other Chemicals stocks on the NSE & BSE. See the full Chemicals sector list.

Anupam Rasayan (ANURAS) Share Price & Financials | NSE | DocStoX